<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://womanwiki.com/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=DawnBrook</id>
	<title>Womanwiki - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://womanwiki.com/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=DawnBrook"/>
	<link rel="alternate" type="text/html" href="https://womanwiki.com/wiki/Special:Contributions/DawnBrook"/>
	<updated>2026-11-22T12:48:22Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.43.9</generator>
	<entry>
		<id>https://womanwiki.com/index.php?title=%E7%AB%99%E7%82%B9%E8%B4%A6%E5%8F%B7%E8%BD%AE%E6%8D%A2%E7%AD%96%E7%95%A5%E8%AF%B4%E6%98%8E&amp;diff=11</id>
		<title>站点账号轮换策略说明</title>
		<link rel="alternate" type="text/html" href="https://womanwiki.com/index.php?title=%E7%AB%99%E7%82%B9%E8%B4%A6%E5%8F%B7%E8%BD%AE%E6%8D%A2%E7%AD%96%E7%95%A5%E8%AF%B4%E6%98%8E&amp;diff=11"/>
		<updated>2026-10-29T08:37:41Z</updated>

		<summary type="html">&lt;p&gt;DawnBrook: [ProfileMax] 发布测试&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== 为什么要轮换站点账号 ==&lt;br /&gt;
&lt;br /&gt;
同一账号在高频发布节奏下容易被站点风控标记,轻则限速、重则封禁。把发布压力均匀摊到站点下的多个账号上,是保持长期可用性的基础手段。&lt;br /&gt;
&lt;br /&gt;
== 轮换策略 ==&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;最近最久未用&#039;&#039;&#039;:每次发布优先选择 lastLoginAt 最靠前的可用账号;&lt;br /&gt;
* &#039;&#039;&#039;失败退避&#039;&#039;&#039;:登录失败或写入被拒的账号直接进入冷却,下一次投递自动换人;&lt;br /&gt;
* &#039;&#039;&#039;凭据分层&#039;&#039;&#039;:active 状态且密码齐全的账号才进入候选池,无凭据账号会被健康检查标 expired。&lt;br /&gt;
&lt;br /&gt;
== 操作约定 ==&lt;br /&gt;
&lt;br /&gt;
批量发布作业按站点串行投递,同一站点同一时刻只占用一个浏览器身份(Profile),发布成功后回写账号最近使用时间,保证轮换计量准确。&lt;br /&gt;
&lt;br /&gt;
轮换器的实现与发布测试共享同一套账号池,压测示范站点为 [https://txwiki.com/wiki/Main_Page Txwiki]。&lt;br /&gt;
&lt;br /&gt;
&amp;lt;blockquote&amp;gt;账号池告警阈值:单站点可用账号少于 2 个时,应导入新凭据而不是压缩发布节奏。&amp;lt;/blockquote&amp;gt;&lt;/div&gt;</summary>
		<author><name>DawnBrook</name></author>
	</entry>
	<entry>
		<id>https://womanwiki.com/index.php?title=%E5%8F%91%E5%B8%83%E8%B4%A8%E9%87%8F%E6%A3%80%E6%9F%A5%E6%B8%85%E5%8D%95&amp;diff=10</id>
		<title>发布质量检查清单</title>
		<link rel="alternate" type="text/html" href="https://womanwiki.com/index.php?title=%E5%8F%91%E5%B8%83%E8%B4%A8%E9%87%8F%E6%A3%80%E6%9F%A5%E6%B8%85%E5%8D%95&amp;diff=10"/>
		<updated>2026-10-29T08:34:34Z</updated>

		<summary type="html">&lt;p&gt;DawnBrook: [ProfileMax] 发布测试&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== 发布后质量检查清单 ==&lt;br /&gt;
&lt;br /&gt;
每一篇发布成功的文章都要过以下检查,任一项不过都应进入修复流程。&lt;br /&gt;
&lt;br /&gt;
=== 基础可达 ===&lt;br /&gt;
&lt;br /&gt;
* 发布页 HTTP 状态码 200(重定向后可达);&lt;br /&gt;
* 页面标题与文章标题一致。&lt;br /&gt;
&lt;br /&gt;
=== 链接与 rel ===&lt;br /&gt;
&lt;br /&gt;
* 目标链接在页面 HTML 中存在且 href 与投放计划一致;&lt;br /&gt;
* rel 属性按投放计划携带(nofollow/sponsored 等),缺失记 missing;&lt;br /&gt;
* 无死链(跳转后 404 即 dead)。&lt;br /&gt;
&lt;br /&gt;
=== 排版与内容 ===&lt;br /&gt;
&lt;br /&gt;
* HTML→wikitext 转换无内容丢失(标题/列表/加粗原样保留);&lt;br /&gt;
* 段落无明显截断,末尾完整。&lt;br /&gt;
&lt;br /&gt;
示范站点 [https://txwiki.com/wiki/Main_Page Txwiki] 的检查记录可在「发布 → 质量评分」Tab 查询。&lt;/div&gt;</summary>
		<author><name>DawnBrook</name></author>
	</entry>
	<entry>
		<id>https://womanwiki.com/index.php?title=%E7%AB%99%E7%82%B9%E8%B4%A6%E5%8F%B7%E8%BD%AE%E6%8D%A2%E7%AD%96%E7%95%A5%E8%AF%B4%E6%98%8E&amp;diff=9</id>
		<title>站点账号轮换策略说明</title>
		<link rel="alternate" type="text/html" href="https://womanwiki.com/index.php?title=%E7%AB%99%E7%82%B9%E8%B4%A6%E5%8F%B7%E8%BD%AE%E6%8D%A2%E7%AD%96%E7%95%A5%E8%AF%B4%E6%98%8E&amp;diff=9"/>
		<updated>2026-10-29T08:32:12Z</updated>

		<summary type="html">&lt;p&gt;DawnBrook: [ProfileMax] 发布测试&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== 为什么要轮换站点账号 ==&lt;br /&gt;
&lt;br /&gt;
同一账号在高频发布节奏下容易被站点风控标记,轻则限速、重则封禁。把发布压力均匀摊到站点下的多个账号上,是保持长期可用性的基础手段。&lt;br /&gt;
&lt;br /&gt;
== 轮换策略 ==&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;最近最久未用&#039;&#039;&#039;:每次发布优先选择 lastLoginAt 最靠前的可用账号;&lt;br /&gt;
* &#039;&#039;&#039;失败退避&#039;&#039;&#039;:登录失败或写入被拒的账号直接进入冷却,下一次投递自动换人;&lt;br /&gt;
* &#039;&#039;&#039;凭据分层&#039;&#039;&#039;:active 状态且密码齐全的账号才进入候选池,无凭据账号会被健康检查标 expired。&lt;br /&gt;
&lt;br /&gt;
== 操作约定 ==&lt;br /&gt;
&lt;br /&gt;
批量发布作业按站点串行投递,同一站点同一时刻只占用一个浏览器身份(Profile),发布成功后回写账号最近使用时间,保证轮换计量准确。&lt;br /&gt;
&lt;br /&gt;
&amp;lt;blockquote&amp;gt;账号池告警阈值:单站点可用账号少于 2 个时,应导入新凭据而不是压缩发布节奏。&amp;lt;/blockquote&amp;gt;&lt;/div&gt;</summary>
		<author><name>DawnBrook</name></author>
	</entry>
	<entry>
		<id>https://womanwiki.com/index.php?title=MediaWiki_%E6%89%B9%E9%87%8F%E5%8F%91%E5%B8%83%E6%8C%87%E5%8D%97(%E5%8E%8B%E6%B5%8B%E7%89%88)&amp;diff=8</id>
		<title>MediaWiki 批量发布指南(压测版)</title>
		<link rel="alternate" type="text/html" href="https://womanwiki.com/index.php?title=MediaWiki_%E6%89%B9%E9%87%8F%E5%8F%91%E5%B8%83%E6%8C%87%E5%8D%97(%E5%8E%8B%E6%B5%8B%E7%89%88)&amp;diff=8"/>
		<updated>2026-10-29T08:28:27Z</updated>

		<summary type="html">&lt;p&gt;DawnBrook: [ProfileMax] 发布测试&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== 为什么做批量发布压测 ==&lt;br /&gt;
&lt;br /&gt;
批量发布的价值不只在吞吐量,更在于把「发布成功率」从主观印象变成可验证的指标:站点可用性、凭据有效性、落栈结果、以及发布后的回读校验,全部由系统记录并汇总成质量评分。&lt;br /&gt;
&lt;br /&gt;
本轮压测使用 15 个 MediaWiki 压测站点,每个站点绑定一个专属发布镜像(指纹浏览器 Profile)与站点账号池,发布作业由调度器按站点串行投递,避免同账号并发发布触发风控。&lt;br /&gt;
&lt;br /&gt;
== 账号导入与凭据管理 ==&lt;br /&gt;
&lt;br /&gt;
* 站点账号密码在导入时即以 AES-256-GCM 加密落库,API 永不返回明文,只在投递时解密注入执行载荷;&lt;br /&gt;
* 每个站点保留原始创建时间与最近登录时间,账号轮换按「最近最久未用」进行;&lt;br /&gt;
* 无有效凭据的账号会被健康检查标记为 expired,不再进入投递候选。&lt;br /&gt;
&lt;br /&gt;
== 发布流程与回读校验 ==&lt;br /&gt;
&lt;br /&gt;
发布作业分两种模式:&#039;&#039;&#039;publish&#039;&#039;&#039; 直接落正式页面,&#039;&#039;&#039;draft&#039;&#039;&#039; 落到账号个人空间的沙盒页,用于在不动正式内容的前提下验证登录与写入链路。落栈成功后系统记录 revisionId,并用 HTTP 回读发布页:确认页面可访问(HTTP 200)、目标链接存在且 rel 属性符合预期。&lt;br /&gt;
&lt;br /&gt;
&amp;lt;blockquote&amp;gt;发布结果(status/message/revisionId/articleUrl)与目标链接检查记录都会在「发布任务 / 质量评分」Tab 中按站点汇总,压测结论以这两处数据为准。&amp;lt;/blockquote&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== 压测站点附录 ==&lt;br /&gt;
&lt;br /&gt;
本轮参与压测的站点包括 youngwiki、eastwiki、hopewiki 等 15 个 MediaWiki 环境,完整站点清单见「发布 → 站点」Tab;示范站点为 [https://txwiki.com/wiki/Main_Page 压测站点 Txwiki]。&lt;/div&gt;</summary>
		<author><name>DawnBrook</name></author>
	</entry>
	<entry>
		<id>https://womanwiki.com/index.php?title=Can_a_Simple_Daily_Fiber_Supplement_Ease_Arthritis_Pain%3F_Inside_the_Gut%E2%80%93Joint_Connection&amp;diff=7</id>
		<title>Can a Simple Daily Fiber Supplement Ease Arthritis Pain? Inside the Gut–Joint Connection</title>
		<link rel="alternate" type="text/html" href="https://womanwiki.com/index.php?title=Can_a_Simple_Daily_Fiber_Supplement_Ease_Arthritis_Pain%3F_Inside_the_Gut%E2%80%93Joint_Connection&amp;diff=7"/>
		<updated>2026-10-28T19:49:35Z</updated>

		<summary type="html">&lt;p&gt;DawnBrook: Knee osteoarthritis is one of the most common causes of chronic joint pain, and the options for managing it can feel limited: exercise, medication, physical therapy, or, eventually, surgery. A new clinical trial has now added an unexpected possibilit&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Knee osteoarthritis is one of the most common causes of chronic joint pain, and the options for managing it can feel limited: exercise, medication, physical therapy, or, eventually, surgery. A new clinical trial has now added an unexpected possibility to that picture. According to the study, a simple daily fiber supplement was associated with significantly less knee pain, stronger muscles, and a body that reacts less intensely to pain. Even more striking, researchers traced these benefits to an unlikely place — the community of bacteria living in the gut — and to a hormone called GLP-1 that has recently become one of the most talked-about molecules in medicine.&lt;br /&gt;
&lt;br /&gt;
== What the finding is ==&lt;br /&gt;
&lt;br /&gt;
A new clinical trial suggests that a simple daily fiber supplement could significantly reduce knee osteoarthritis pain, improve muscle strength, and make the body less sensitive to pain. The supplement used in the study was inulin, a naturally occurring dietary fiber. Researchers discovered that the benefits may be linked to changes in gut bacteria and the hormone GLP-1, revealing a promising new approach to arthritis relief.&lt;br /&gt;
&lt;br /&gt;
The trial assigned participants to one of two approaches: an inulin supplement taken on its own, or physical therapy on its own. One of the most practical observations from the study concerned adherence — whether people actually stuck with the program they were given. Only 3.6% of those assigned to inulin alone dropped out of the study, compared with 21% of those assigned to physical therapy alone. Dropout rates do not, by themselves, measure how well a treatment works, but they do say something about how easy a regimen is to live with. In this trial, a daily fiber supplement proved considerably easier for participants to sustain than a schedule of regular physical therapy sessions.&lt;br /&gt;
&lt;br /&gt;
Alongside the improvements in pain and strength, the researchers also observed higher levels of glucagon-like peptide-1, better known as GLP-1. This is a hormone released by the gut that helps regulate blood sugar and appetite and has also been linked to pain regulation and muscle health. One particularly interesting finding was that higher GLP-1 levels were associated with better grip strength — a simple, hands-on measure of how well the muscles are functioning.&lt;br /&gt;
&lt;br /&gt;
== Core concepts ==&lt;br /&gt;
&lt;br /&gt;
=== Knee osteoarthritis ===&lt;br /&gt;
&lt;br /&gt;
Osteoarthritis is the most common form of arthritis. It develops when the cartilage that cushions the ends of bones in a joint gradually wears down, leaving the joint painful, stiff, and sometimes swollen. The knee is especially vulnerable because it carries the weight of the body through every step. Traditional management includes exercise, weight management, pain-relieving medication, and physical therapy, all of which aim to reduce pain and preserve mobility rather than reverse the underlying damage.&lt;br /&gt;
&lt;br /&gt;
=== Inulin: an ordinary fiber with an unusual role ===&lt;br /&gt;
&lt;br /&gt;
Inulin is a type of dietary fiber found naturally in plants such as chicory root, onions, garlic, and bananas. Like other fibers, it cannot be broken down by human digestive enzymes. Instead, it travels intact to the colon, where gut bacteria ferment it. Because it serves as food for beneficial microbes, inulin is often described as a prebiotic fiber. In the trial, it was taken as a simple daily supplement — no exotic ingredients and no hormonal drugs.&lt;br /&gt;
&lt;br /&gt;
=== The gut microbiome ===&lt;br /&gt;
&lt;br /&gt;
The human gut hosts an enormous community of bacteria and other microbes, collectively known as the gut microbiome. These microbes do far more than aid digestion. When they ferment fiber, they produce compounds that can influence metabolism, the immune system, and even the way the nervous system processes pain. The microbiome is also remarkably responsive to diet, which is why a change in daily fiber intake can lead to measurable changes in gut bacteria — the kind of changes the trial&#039;s researchers observed.&lt;br /&gt;
&lt;br /&gt;
=== GLP-1: from gut hormone to household name ===&lt;br /&gt;
&lt;br /&gt;
GLP-1, short for glucagon-like peptide-1, is a hormone released by the gut that helps regulate blood sugar and appetite. It has also been linked to pain regulation and muscle health, which is what makes it relevant to arthritis research. In recent years, GLP-1 has attracted widespread attention because it is the hormone targeted by medications such as Ozempic and Wegovy. It is important to note, however, that the inulin supplement used in this trial was not a GLP-1 medication. The fiber worked indirectly, by influencing the body&#039;s own biology rather than delivering a drug.&lt;br /&gt;
&lt;br /&gt;
== How it works ==&lt;br /&gt;
&lt;br /&gt;
The mechanism proposed by the researchers runs like a chain. First, the daily inulin reaches the colon largely undigested. There, gut bacteria ferment it, and over time the composition and activity of the bacterial community shift. These changes in gut bacteria appear to influence the hormones the gut releases — most notably GLP-1. Because GLP-1 has been linked to pain regulation and muscle health, a rise in this hormone offers a plausible explanation for the trial&#039;s two headline effects: the body becoming less sensitive to pain and the muscles becoming stronger.&lt;br /&gt;
&lt;br /&gt;
The trial&#039;s own observations support different links in this chain. Participants taking the fiber supplement showed higher levels of GLP-1, and higher GLP-1 levels were associated with better grip strength. That grip strength finding stood out to the researchers as particularly interesting, because grip strength is an easy, objective way to track muscle function. It suggests that the fiber&#039;s influence may extend beyond the painful knee to muscle performance in general.&lt;br /&gt;
&lt;br /&gt;
The researchers&#039; own language remains appropriately cautious. They describe the benefits as &#039;&#039;possibly&#039;&#039; linked to gut bacteria and GLP-1 — an association rather than a proven cause-and-effect mechanism. A single clinical trial, however encouraging, cannot definitively establish how the gut and the joint communicate, and the findings will need to be confirmed by further research. What the trial does show clearly is that the intervention itself was easy to live with: with only 3.6% of the fiber group dropping out versus 21% of the physical therapy group, the study suggests that a simple supplement routine is something many people can maintain over the long term — a factor that matters, because any therapy only works if people keep doing it.&lt;br /&gt;
&lt;br /&gt;
It is equally important to note what the trial does not show. It does not indicate that fiber should replace established treatments, and it does not involve GLP-1 medications of the kind prescribed under names like Ozempic and Wegovy. The inulin supplement was an ordinary dietary fiber, not a drug.&lt;br /&gt;
&lt;br /&gt;
== Common questions ==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Is this the same as taking Ozempic or Wegovy?&#039;&#039;&#039; No. Those medications work by directly targeting the GLP-1 hormone, which is why GLP-1 has attracted so much public attention. The supplement tested in&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
* [https://www.sciencedaily.com/releases/2026/10/261027230715.htm A simple daily fiber supplement reduced arthritis pain and improved strength | ScienceDaily]&lt;br /&gt;
&lt;br /&gt;
[[Category:researchers]]&lt;br /&gt;
[[Category:glp-1]]&lt;br /&gt;
[[Category:and]]&lt;br /&gt;
[[Category:the]]&lt;br /&gt;
[[Category:to]]&lt;/div&gt;</summary>
		<author><name>DawnBrook</name></author>
	</entry>
</feed>